nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—ADRA2C—Hemostasis—SELL—abdominal aortic aneurysm	0.00629	0.00629	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.00623	0.00623	CbGpPWpGaD
Xylometazoline—HTR1D—G alpha (i) signalling events—AGT—abdominal aortic aneurysm	0.0062	0.0062	CbGpPWpGaD
Xylometazoline—HTR1B—G alpha (i) signalling events—AGT—abdominal aortic aneurysm	0.00607	0.00607	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—P2RY12—abdominal aortic aneurysm	0.00606	0.00606	CbGpPWpGaD
Xylometazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.006	0.006	CbGpPWpGaD
Xylometazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.00599	0.00599	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—abdominal aortic aneurysm	0.00597	0.00597	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.00591	0.00591	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.00581	0.00581	CbGpPWpGaD
Xylometazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.0057	0.0057	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—P2RY12—abdominal aortic aneurysm	0.00566	0.00566	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.00553	0.00553	CbGpPWpGaD
Xylometazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.00542	0.00542	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00534	0.00534	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.00532	0.00532	CbGpPWpGaD
Xylometazoline—ADRA1B—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.00529	0.00529	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00523	0.00523	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.00516	0.00516	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.00514	0.00514	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—SELL—abdominal aortic aneurysm	0.00511	0.00511	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.00506	0.00506	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.00498	0.00498	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00496	0.00496	CbGpPWpGaD
Xylometazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00493	0.00493	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00485	0.00485	CbGpPWpGaD
Xylometazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00483	0.00483	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.0048	0.0048	CbGpPWpGaD
Xylometazoline—ADRA2B—G alpha (i) signalling events—AGT—abdominal aortic aneurysm	0.00479	0.00479	CbGpPWpGaD
Xylometazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.00473	0.00473	CbGpPWpGaD
Xylometazoline—ADRA1A—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.0047	0.0047	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—P2RY12—abdominal aortic aneurysm	0.0046	0.0046	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00457	0.00457	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.0045	0.0045	CbGpPWpGaD
Xylometazoline—ADRA2C—G alpha (i) signalling events—AGT—abdominal aortic aneurysm	0.00448	0.00448	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.00442	0.00442	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00441	0.00441	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00424	0.00424	CbGpPWpGaD
Xylometazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00422	0.00422	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.0042	0.0042	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00412	0.00412	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.00411	0.00411	CbGpPWpGaD
Xylometazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00406	0.00406	CbGpPWpGaD
Xylometazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00398	0.00398	CbGpPWpGaD
Xylometazoline—ADRA2B—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.00387	0.00387	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00385	0.00385	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00385	0.00385	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00383	0.00383	CbGpPWpGaD
Xylometazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00381	0.00381	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00379	0.00379	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00376	0.00376	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00368	0.00368	CbGpPWpGaD
Xylometazoline—ADRA2A—G alpha (i) signalling events—AGT—abdominal aortic aneurysm	0.00364	0.00364	CbGpPWpGaD
Xylometazoline—ADRA2C—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.00362	0.00362	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00358	0.00358	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00356	0.00356	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00352	0.00352	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.0035	0.0035	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00348	0.00348	CbGpPWpGaD
Xylometazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00348	0.00348	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00337	0.00337	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00325	0.00325	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00321	0.00321	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.0032	0.0032	CbGpPWpGaD
Xylometazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00314	0.00314	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00313	0.00313	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00313	0.00313	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00311	0.00311	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00309	0.00309	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00303	0.00303	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00302	0.00302	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00295	0.00295	CbGpPWpGaD
Xylometazoline—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.00294	0.00294	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00293	0.00293	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00291	0.00291	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.0029	0.0029	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00289	0.00289	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00289	0.00289	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00284	0.00284	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00284	0.00284	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00278	0.00278	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00274	0.00274	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00271	0.00271	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00268	0.00268	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00267	0.00267	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00266	0.00266	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00265	0.00265	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00264	0.00264	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.0026	0.0026	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00258	0.00258	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00256	0.00256	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00244	0.00244	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00243	0.00243	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00239	0.00239	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00239	0.00239	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00238	0.00238	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00237	0.00237	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—NOS2—abdominal aortic aneurysm	0.00237	0.00237	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00234	0.00234	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00233	0.00233	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00228	0.00228	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00223	0.00223	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—NOS2—abdominal aortic aneurysm	0.00221	0.00221	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.0022	0.0022	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.0022	0.0022	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.0022	0.0022	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00218	0.00218	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00215	0.00215	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00214	0.00214	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—AAAS—abdominal aortic aneurysm	0.00213	0.00213	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00212	0.00212	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00212	0.00212	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00211	0.00211	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00209	0.00209	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00208	0.00208	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00205	0.00205	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00205	0.00205	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00202	0.00202	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00202	0.00202	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.002	0.002	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00198	0.00198	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00197	0.00197	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00195	0.00195	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00195	0.00195	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00193	0.00193	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00192	0.00192	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.0019	0.0019	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00189	0.00189	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00189	0.00189	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00189	0.00189	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.00186	0.00186	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—LDLR—abdominal aortic aneurysm	0.00186	0.00186	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00184	0.00184	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00182	0.00182	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00181	0.00181	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—NOS2—abdominal aortic aneurysm	0.0018	0.0018	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00179	0.00179	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00177	0.00177	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00176	0.00176	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00173	0.00173	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AAAS—abdominal aortic aneurysm	0.00173	0.00173	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00173	0.00173	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00172	0.00172	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00168	0.00168	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00167	0.00167	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00166	0.00166	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00165	0.00165	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00164	0.00164	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00162	0.00162	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00161	0.00161	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.00159	0.00159	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00158	0.00158	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00156	0.00156	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00156	0.00156	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00156	0.00156	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.00155	0.00155	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00154	0.00154	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00153	0.00153	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00153	0.00153	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.00151	0.00151	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—LDLR—abdominal aortic aneurysm	0.00151	0.00151	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00151	0.00151	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00149	0.00149	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00145	0.00145	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00144	0.00144	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00143	0.00143	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00143	0.00143	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00141	0.00141	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00139	0.00139	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00139	0.00139	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00137	0.00137	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00136	0.00136	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.00136	0.00136	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00134	0.00134	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00127	0.00127	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00126	0.00126	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00125	0.00125	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00124	0.00124	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00123	0.00123	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.00123	0.00123	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00122	0.00122	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00118	0.00118	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00117	0.00117	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00115	0.00115	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.00115	0.00115	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00114	0.00114	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00113	0.00113	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.00113	0.00113	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—APOE—abdominal aortic aneurysm	0.00112	0.00112	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00112	0.00112	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00111	0.00111	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—APOE—abdominal aortic aneurysm	0.00109	0.00109	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00104	0.00104	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00102	0.00102	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00102	0.00102	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.001	0.001	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—AGT—abdominal aortic aneurysm	0.000983	0.000983	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000975	0.000975	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—APOE—abdominal aortic aneurysm	0.000963	0.000963	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000955	0.000955	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000949	0.000949	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000938	0.000938	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000931	0.000931	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000918	0.000918	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00091	0.00091	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00088	0.00088	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000876	0.000876	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000862	0.000862	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000857	0.000857	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000846	0.000846	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000822	0.000822	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000809	0.000809	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000805	0.000805	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000803	0.000803	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AGT—abdominal aortic aneurysm	0.000798	0.000798	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000793	0.000793	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—APOE—abdominal aortic aneurysm	0.000782	0.000782	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000749	0.000749	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000725	0.000725	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000719	0.000719	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000704	0.000704	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000677	0.000677	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000677	0.000677	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000671	0.000671	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000668	0.000668	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000666	0.000666	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000664	0.000664	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PTGS2—abdominal aortic aneurysm	0.00066	0.00066	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000657	0.000657	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000654	0.000654	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.00065	0.00065	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000632	0.000632	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000622	0.000622	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000592	0.000592	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000574	0.000574	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000568	0.000568	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000552	0.000552	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.00055	0.00055	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTGS2—abdominal aortic aneurysm	0.000536	0.000536	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000518	0.000518	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000513	0.000513	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000513	0.000513	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000484	0.000484	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000479	0.000479	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000476	0.000476	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000471	0.000471	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000423	0.000423	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000419	0.000419	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000393	0.000393	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000389	0.000389	CbGpPWpGaD
